Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Perrin

Antiviral therapy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Antiviral Therapy|July 19, 2005
Primary HIV infectionL Perrin
Antiviral Therapy|August 1, 1996
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsS Yerly, N Denereaz, B Mermillod, et al.
Antiviral Therapy|January 26, 2002
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavirS Yerly, M Rickenbach, M Popescu, et al.
Antiviral Therapy|January 1, 1997
Zidovudine plus didanosine in primary HIV-1 infectionL Perrin, S Yerly, A Charvier, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Antiviral Therapy|July 19, 2005
Primary HIV infectionL Perrin
Antiviral Therapy|August 1, 1996
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsS Yerly, N Denereaz, B Mermillod, et al.
Antiviral Therapy|January 26, 2002
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavirS Yerly, M Rickenbach, M Popescu, et al.
Antiviral Therapy|January 1, 1997
Zidovudine plus didanosine in primary HIV-1 infectionL Perrin, S Yerly, A Charvier, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 1